Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Darcis

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Revue Medicale De Liege|June 8, 2026
[Monkeypox virus (mpox) reemergence and One Health : from concept to global reality]Majdouline El Moussaoui, Gilles Darcis
Revue Medicale De Liege|June 8, 2026
[«One Health», a major contemporary issue]Gilles Darcis, Nicolas Antoine-Moussiaux
Epidemiology and Infection|August 25, 2020
Impact of coronavirus pandemic and containment measures on HIV diagnosisGilles Darcis, Dolores Vaira, Michel Moutschen
Viruses|March 30, 2018
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock StrategiesGilles Darcis, Atze T Das, Ben Berkhout
Frontiers in Immunology|October 17, 2019
The Quest for Cellular Markers of HIV Reservoirs: Any Color You LikeGilles Darcis, Ben Berkhout, Alexander O Pasternak
Revue Medicale Suisse|July 4, 2017
[Update in HIV therapy: tenofovir alafenamide]Anne-Sophie Sauvage, Gilles Darcis, Michel Moutschen
Viruses|May 1, 2020
Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral ReservoirsGilles Darcis, Ben Berkhout, Alexander O Pasternak
Annual Review of Virology|September 29, 2021
The Current Status of Latency Reversing Agents for HIV-1 RemissionAnthony Rodari, Gilles Darcis, Carine M Van Lint
Trends in Immunology|January 12, 2017
HIV Latency: Should We Shock or Lock?Gilles Darcis, Benoit Van Driessche, Carine Van Lint
Antimicrobial Resistance and Infection Control|February 20, 2026
Evaluation of piperacillin-tazobactam appropriateness and underlying drivers of inappropriate prescribing in a Belgian University Hospital: a retrospective studyVéronique Goncette, Catherine Orban, Nathalie Maes, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Revue Medicale De Liege|June 8, 2026
[Monkeypox virus (mpox) reemergence and One Health : from concept to global reality]Majdouline El Moussaoui, Gilles Darcis
Revue Medicale De Liege|June 8, 2026
[«One Health», a major contemporary issue]Gilles Darcis, Nicolas Antoine-Moussiaux
Epidemiology and Infection|August 25, 2020
Impact of coronavirus pandemic and containment measures on HIV diagnosisGilles Darcis, Dolores Vaira, Michel Moutschen
Viruses|March 30, 2018
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock StrategiesGilles Darcis, Atze T Das, Ben Berkhout
Frontiers in Immunology|October 17, 2019
The Quest for Cellular Markers of HIV Reservoirs: Any Color You LikeGilles Darcis, Ben Berkhout, Alexander O Pasternak
Revue Medicale Suisse|July 4, 2017
[Update in HIV therapy: tenofovir alafenamide]Anne-Sophie Sauvage, Gilles Darcis, Michel Moutschen
Viruses|May 1, 2020
Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral ReservoirsGilles Darcis, Ben Berkhout, Alexander O Pasternak
Annual Review of Virology|September 29, 2021
The Current Status of Latency Reversing Agents for HIV-1 RemissionAnthony Rodari, Gilles Darcis, Carine M Van Lint
Trends in Immunology|January 12, 2017
HIV Latency: Should We Shock or Lock?Gilles Darcis, Benoit Van Driessche, Carine Van Lint
Antimicrobial Resistance and Infection Control|February 20, 2026
Evaluation of piperacillin-tazobactam appropriateness and underlying drivers of inappropriate prescribing in a Belgian University Hospital: a retrospective studyVéronique Goncette, Catherine Orban, Nathalie Maes, et al.
Pageof 9